ArticleJournal of clinical medicine2024

Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study.

Paolo Gallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.